These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31065321)

  • 1. [Renal failure revealing multiple myeloma with preexisting lesions on radiological images].
    Bouchemla N; Nadri A; Chettati M; Fadili W; Laouad I
    Pan Afr Med J; 2018; 31():171. PubMed ID: 31065321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function.
    Nozza A; Siracusano L; Armando S
    Clin Ther; 2006 Jun; 28(6):953-9. PubMed ID: 16860177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of patients with multiple myeloma and renal failure on novel regimens.
    Soleymanian T; Soleimani A; Musavi A; Mojtahedi K; Hamid G
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):335-40. PubMed ID: 26997388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
    Bianchi G; Richardson PG; Anderson KC
    J Clin Oncol; 2014 Jul; 32(20):2125-32. PubMed ID: 24888801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgD kappa myeloma: a new case.
    Amine B; Benbouazza K; Harzy T; Rahmouni R; Guedira N; Lazrak N; Hajjaj-Hassouni N
    Joint Bone Spine; 2004 Jul; 71(4):331-3. PubMed ID: 15288860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma associated with an Evan's syndrome.
    Bechir A; Haifa R; Nesrine BS; Emna B; Senda M; Asma A; Amina BB; Mrabet S; Yosra BY; Mondher K; Abderrahim K
    Pan Afr Med J; 2016; 25():127. PubMed ID: 28292089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of patients with multiple myeloma and renal impairment treated with bortezomib, cyclophosphamide, and dexamethasone without plasma exchange.
    Costa LJ; Abbas J; Ortiz-Cruz KL; Kang Y; Stuart RK
    Eur J Haematol; 2012 Nov; 89(5):432-4. PubMed ID: 22971164
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Relapsed Myeloma in a Patient With Renal Insufficiency.
    Bladé J; Rosiñol L; Cibeira MT; Fernández de Larrea C
    J Clin Oncol; 2018 Jul; 36(20):2012-2016. PubMed ID: 29851545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Withdrawal of maintenance dialysis in a patient with diagnosed multiple myeloma and renal failure as a consequence of effective anti-tumor treatment].
    Rosa J; Sydor A; Jurczyszyn A; Zabawa-Hołyś S; Nowak J; Czapkowicz-Gryszkiewicz L; Sułowicz W
    Przegl Lek; 2010; 67(7):547-50. PubMed ID: 21387773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complete remission achieved in a multiple myeloma patient with elevated serum KL-6 level by a combination regimen with bortezomib, cyclophosphamide, and dexamethasone].
    Okuno Y; Nishimura N; Nosaka K; Hata H; Mitsuya H
    Rinsho Ketsueki; 2014 Apr; 55(4):461-5. PubMed ID: 24850459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Achievement of hemodialysis discontinuation with lenalidomide and dexamethasone therapy in a refractory BJP-type multiple myeloma patient].
    Uchida T; Inoue M; Hua J; Hagihara M
    Rinsho Ketsueki; 2016 May; 57(5):613-7. PubMed ID: 27263787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical profile of multiple myeloma and effect of thalidomide based treatment on its outcome.
    Sridhar S; Dutta TK; Basu D
    J Indian Med Assoc; 2011 Dec; 109(12):880-2, 887-8. PubMed ID: 23469567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
    Tosi P; Zamagni E; Cellini C; Cangini D; Tacchetti P; Tura S; Baccarani M; Cavo M
    Eur J Haematol; 2004 Aug; 73(2):98-103. PubMed ID: 15245508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute renal failure in IgM plasmocytoma with hyperviscosity syndrome].
    Nitschke M; Fink K; Pawlow-Handt S; Leeker A; Rob PM; Steinhoff J
    Dtsch Med Wochenschr; 1997 Oct; 122(40):1213-6. PubMed ID: 9378045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma.
    Dimopoulos MA; Roussou M; Gkotzamanidou M; Nikitas N; Psimenou E; Mparmparoussi D; Matsouka C; Spyropoulou-Vlachou M; Terpos E; Kastritis E
    Leukemia; 2013 Feb; 27(2):423-9. PubMed ID: 22763386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic inflammatory response with high CRP values as the dominant symptom of multiple myeloma].
    Král Z; Adam Z; Folber F; Moulis M; Tomíška M; Říhová L; Štork M; Buliková A; Pour L; Krejčí M; Sandecká V; Koukalová R; Řehák Z; Čermáková Z
    Vnitr Lek; 2019; 65(1):37-44. PubMed ID: 30823836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
    Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M
    Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma--presenting as acute kidney injury.
    Prakash J; Niwas SS; Parekh A; Vohra R; Wani IA; Sharma N; Usha
    J Assoc Physicians India; 2009 Jan; 57():23-6. PubMed ID: 19753754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma.
    Weisel KC; Dimopoulos MA; Moreau P; Lacy MQ; Song KW; Delforge M; Karlin L; Goldschmidt H; Banos A; Oriol A; Alegre A; Chen C; Cavo M; Garderet L; Ivanova V; Martinez-Lopez J; Knop S; Yu X; Hong K; Sternas L; Jacques C; Zaki MH; San Miguel J
    Haematologica; 2016 Jul; 101(7):872-8. PubMed ID: 27081177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment.
    Bridoux F; Chen N; Moreau S; Arnulf B; Moumas E; Abraham J; Desport E; Jaccard A; Fermand JP
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):173-82. PubMed ID: 27286995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.